Targeting the Pathways to Better Health

Our Mission

Intellikine is discovering and developing innovative, small molecule drugs that target signal transduction networks for the treatment of cancer, inflammation and autoimmune diseases. Learn More

Upcoming Events

JP Morgan Healthcare Conference
January 11-14, 2010 / San Francisco

Allicense 2010
May 25-26, 2010 / San Francisco

Learn More

Pipeline

Our pipeline programs include both novel isoform-selective and pathway-selective inhibitors of members of the PI3K/Akt/mTOR signaling network.

Learn More

News

Intellikine announces three-dimensional crystal structure of important drug target.

Learn More